XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 101 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,739,000 | -45.5% | 1,525,808 | -9.4% | 0.00% | – |
| Q2 2021 | $6,855,000 | -59.6% | 1,684,166 | -55.3% | 0.00% | – |
| Q1 2021 | $16,981,000 | -5.4% | 3,764,948 | +3.2% | 0.00% | -100.0% |
| Q4 2020 | $17,943,000 | -14.6% | 3,647,218 | +2.9% | 0.00% | 0.0% |
| Q3 2020 | $21,008,000 | +180.5% | 3,542,830 | +25.9% | 0.00% | – |
| Q2 2020 | $7,489,000 | +64.4% | 2,814,848 | +20.5% | 0.00% | – |
| Q1 2020 | $4,555,000 | -70.6% | 2,336,418 | +6.4% | 0.00% | -100.0% |
| Q4 2019 | $15,488,000 | -26.1% | 2,196,747 | +3.1% | 0.00% | 0.0% |
| Q3 2019 | $20,949,000 | -14.4% | 2,131,249 | -0.4% | 0.00% | 0.0% |
| Q2 2019 | $24,468,000 | +36.1% | 2,138,781 | +19.5% | 0.00% | 0.0% |
| Q1 2019 | $17,977,000 | +63.9% | 1,790,473 | +177.6% | 0.00% | 0.0% |
| Q4 2018 | $10,966,000 | +58.2% | 645,035 | +63.5% | 0.00% | – |
| Q3 2018 | $6,933,000 | +1359.6% | 394,416 | +1477.7% | 0.00% | – |
| Q2 2018 | $475,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 4,172,459 | $20,528,000 | 1.31% |
| DELTEC ASSET MANAGEMENT LLC | 693,870 | $3,414,000 | 0.52% |
| Alpine Global Management, LLC | 350,000 | $1,722,000 | 0.35% |
| Redmile Group, LLC | 2,397,441 | $11,795,000 | 0.14% |
| Kamunting Street Capital Management, L.P. | 43,833 | $216,000 | 0.11% |
| IHT Wealth Management, LLC | 250,798 | $1,234,000 | 0.10% |
| SEARLE & CO. | 34,000 | $167,000 | 0.08% |
| GPS Wealth Strategies Group, LLC | 46,025 | $226,000 | 0.08% |
| ArrowMark Colorado Holdings LLC | 1,981,909 | $9,751,000 | 0.08% |
| Gladstone Institutional Advisory LLC | 51,500 | $253 | 0.05% |